Albert Bourla, Pfizer CEO (Michel Euler/AP Images, Pool)

More than a year af­ter its emer­gency au­tho­riza­tion, FDA ful­ly ap­proves Pfiz­er's Covid pill Paxlovid for adults

More than 510 days since first earn­ing an emer­gency use au­tho­riza­tion, Pfiz­er’s life-sav­ing Covid-19 pill Paxlovid (nir­ma­trelvir and ri­ton­avir) fi­nal­ly

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.